Long-Term Omalizumab in Elderly Patients with Chronic Urticaria: Is It a Safe Therapy?
Narváez-Fernández EJ, Entrala A, Nin-Valencia A, Mir-Ihara P, Losantos-García I, Domínguez-Ortega J, González-Fernández MÁ, Quirce S, Hernández-Cano N, Cabañas R, Caballero T.
Narváez-Fernández EJ, et al. Among authors: entrala a.
Int Arch Allergy Immunol. 2023;184(10):1003-1009. doi: 10.1159/000530494. Epub 2023 May 23.
Int Arch Allergy Immunol. 2023.
PMID: 37231812